Orforglipron
Orforglipron is a new class of chemically synthesized oral non peptide drugs
Orforglipron 
Products Description
Orforglipron is a new class of chemically synthesized oral non peptide drugs. It can play a powerful anti diabetes role by enhancing glucose dependent insulin secretion and improving energy balance. This drug not only performs outstandingly in the field of lowering blood sugar, but also shows great potential for application in weight management (weight loss); According to the currently published clinical data, its efficacy and safety are comparable to injectable GLP-1 receptor agonists.
Products advantage
Core advantages of Xi'an Tihealth Orforglipron
1. Excellent quality, precise compliance with standards
Ultra high purity guarantee: Batch stability achieved>99.7%
2. Compliant production, fully traceable throughout the process
Full chain quality control system: strictly follow the dual standard production process of GMP and ISO 9001
3. Multi scenario adaptability
Meet the requirements of multiple fields such as pharmaceuticals, active ingredient addition in high-end cosmetics, and research on food additives.
Support customized services
4. Reliable supply, guaranteed production capacity, worry free cooperation
Choosing Orforge lipon from Xi'an Tihealth means choosing a verifiable quality cornerstone and compliant supply chain guarantee, significantly reducing your process development risks and compliance costs, and focusing on high-value end product development.
Products Core Benefits
Orforglipron has the following proven benefits and potential advantages:
1. Reduce visceral fat
2. Improve muscle loss
3. Scientific methods for body weight loss
4. Efficient regulation of blood sugar
5. Improve endothelial function of blood vessels
⚠️ Important boundaries that need to be clearly defined
Non direct health declaration
The above benefits are based on the physiological mechanisms of drug active ingredients and clinical trial population data
Individual effects are influenced by factors such as dosage, underlying diseases, and combination therapy
Target audience restrictions
→ Current research focuses on obese patients with type 2 diabetes and BMI ≥ 30 (or ≥ 27 with complications)
→ Non diabetes population for simple weight loss has not been approved (in the research stage)
Non alternative healthy lifestyle
All efficacy data in the trial were based on the combination of "medication+diet and exercise intervention"
Products Application
Product application:
1. Used for treating chronic obesity
2. Treatment of type 2 diabetes
3. Assist in improving non-alcoholic fatty liver disease (NAFLD)
4. Delaying muscle decline in the elderly;
5. Improve muscle loss associated with chronic diseases such as chronic kidney disease.
Application note:
It is a prescription drug and should be used according to medical advice; The dosage varies in different scenarios, such as lowering blood sugar and weight loss; Unauthorized indications should not be used beyond the scope.
The core application areas of Orforge lipon raw materials
1. Medical field
Research on the development level of hypoglycemic/weight loss drugs
2. Cosmetics field
Research and development of high-end functional cosmetics
Products FAQ
Q1: Will there be any side effects?
I'm most afraid of hurting my body!
⚠️
Common reactions (clinical trial data):
Gastrointestinal discomfort: About 40% of people experience nausea and diarrhea (mostly occurring a few weeks before medication and gradually decreasing)
• Hypoglycemic risk: Combination with other hypoglycemic drugs may cause palpitations and dizziness
Taboo population: Patients with a history of medullary thyroid cancer and pancreatitis are contraindicated
Safety reminder: Regular check ups of liver and kidney function are required during medication.
Q2: How long does it take to take effect?
Will stopping medication cause a rebound?
⏳
Effect cycle:
• Blood sugar: begins to decrease at 2-4 weeks, significantly improves at 12 weeks
• Weight: Most people lose ≥ 5% in 4 weeks and ≥ 10% in 16 weeks
Rebound risk: 50% of the average weight loss due to rebound within one year of discontinuation in clinical trials, requiring long-term management.
Q3: Can I buy raw materials directly and take them myself?
⛔
Absolutely prohibited!
Raw materials (powders) are not drugs!
Unprocessed formulations may contain toxic impurities
Direct consumption may cause burns to the mouth and esophagus, leading to poisoning
Legal means: In the future, it is necessary to purchase finished drugs from regular hospitals/pharmacies with a prescription.
Q4: Can diabetes patients use it?
✅
Okay!
The Phase II trial showed that:
Significantly reduced blood sugar (HbA1c decreased by 1.5% -2.0%)
Simultaneous weight loss of 8% -10%, killing two birds with one stone
Q5, who can't take this medicine?
Taboo population:
Patient or personal history of medullary thyroid cancer
Patients with multiple endocrine adenoma syndrome
Pregnant and lactating women (safety not verified)


